Anders Österborg
Karolinska University Hospital(SE)Karolinska Institutet(SE)
Publications by Year
Research Areas
Chronic Lymphocytic Leukemia Research, Lymphoma Diagnosis and Treatment, Immunodeficiency and Autoimmune Disorders, Monoclonal and Polyclonal Antibodies Research, Multiple Myeloma Research and Treatments
Most-Cited Works
- → CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group(2006)2,073 cited
- → Ofatumumab As Single-Agent CD20 Immunotherapy in Fludarabine-Refractory Chronic Lymphocytic Leukemia(2010)586 cited
- → Phase II trial of subcutaneous anti-CD52 monoclonal antibody alemtuzumab (Campath-1H) as first-line treatment for patients with B-cell chronic lymphocytic leukemia (B-CLL)(2002)498 cited
- Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: An overview of 6,633 patients from 27 randomized trials(1998)
- → Zanubrutinib or Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia(2022)428 cited
- → EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update(2006)401 cited